Truist downgraded Integral Ad Science (IAS) to Hold from Buy with a price target of $10.30, down from $17, after the company agreed to be acquired by private equity firm Novacap for $10.30 per share in cash.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS:
- Positive Outlook for IAS Following Novacap Acquisition: Buy Rating Affirmed by Analyst Andrew Marok
- Integral Ad Science acquisition by Novacap ‘makes sense,’ says Raymond James
- Integral Ad Science PE takeout a positive, says Barclays
- Integral Ad Science downgraded to Hold from Buy at Craig-Hallum
- Integral Ad Science to be acquired by Novacap for $1.9B in cash